Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces amyloid-β burden in a mouse model of Alzheimer's disease.

There was a strong trend towards reduced expression of PSD-95 in the O-V mice relative to the Y-V mice ( Fig 3A ), consistent with the decreased cognitive function that we observed.

also in 5,725 other papers